BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2138489)

  • 1. Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function.
    Cashman JN; Luke JJ; Jones RM
    Br J Anaesth; 1990 Feb; 64(2):186-92. PubMed ID: 2138489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant.
    Basta SJ; Savarese JJ; Ali HH; Embree PB; Schwartz AF; Rudd GD; Wastila WB
    Anesthesiology; 1988 Oct; 69(4):478-86. PubMed ID: 2972233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular and cardiovascular effects of doxacurium in children anaesthetized with halothane.
    Goudsouzian NG; Alifimoff JK; Liu LM; Foster V; McNulty B; Savarese JJ
    Br J Anaesth; 1989 Mar; 62(3):263-8. PubMed ID: 2522789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children.
    Bevan JC; Purday JP; Reimer EJ; Bevan DR
    Can J Anaesth; 1994 Nov; 41(11):1074-80. PubMed ID: 7828255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
    Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of doxacurium chloride.
    Maddineni VR; Cooper R; Stanley JC; Mirakhur RK; Clarke RS
    Anaesthesia; 1992 Jul; 47(7):554-7. PubMed ID: 1385680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxacurium chloride: a preliminary clinical trial.
    Scott RP; Norman J
    Br J Anaesth; 1989 Apr; 62(4):373-7. PubMed ID: 2523226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Train-of-four recovery after pharmacologic antagonism of pancuronium-, pipecuronium-, and doxacurium-induced neuromuscular block in anaesthetized humans.
    Stinson LW; Lanier WL; Lennon RL
    Acta Anaesthesiol Scand; 1995 Apr; 39(3):406-10. PubMed ID: 7793225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of doxacurium chloride (BW A938U) in children.
    Sarner JB; Brandom BW; Cook DR; Dong ML; Horn MC; Woelfel SK; Davis PJ; Rudd GD; Foster VJ; McNulty BF
    Anesth Analg; 1988 Apr; 67(4):303-6. PubMed ID: 2965532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
    Bartunek A; Gilly H; Huemer G; Yildiz S; Schramm W; Lackner FX; Foldes FF
    Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of edrophonium and neostigmine for the antagonism of atracurium-induced neuromuscular block.
    Lavery GG; Mirakhur RK; Gibson FM
    Anesth Analg; 1985 Sep; 64(9):867-70. PubMed ID: 3161421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relations of doxacurium and its reversal with neostigmine in young adults and healthy elderly patients.
    Koscielniak-Nielsen ZJ; Law-Min JC; Donati F; Bevan DR; Clement P; Wise R
    Anesth Analg; 1992 Jun; 74(6):845-50. PubMed ID: 1534472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of neuromuscular effects and antagonism of rocuronium bromide: a preliminary report.
    Davis L; Jayarajah MJ; Toner CC; Flynn PJ
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():65-8. PubMed ID: 8557009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxacurium chloride for neuromuscular blockade before tracheal intubation and surgery during nitrous oxide-oxygen-narcotic-enflurane anesthesia.
    Lennon RL; Hosking MP; Houck PC; Rose SH; Wedel DJ; Gibson BE; Ascher JA; Rudd GD
    Anesth Analg; 1989 Mar; 68(3):255-60. PubMed ID: 2919763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children.
    Bevan JC; Tousignant C; Stephenson C; Blackman L; Reimer E; Smith MF; Bevan DR
    Anesthesiology; 1996 Feb; 84(2):354-61. PubMed ID: 8602666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.
    Abdulatif M; Al-Ghamdi A; Al-Sanabary M; Abdel-Gaffar ME
    Br J Anaesth; 1996 Feb; 76(2):239-44. PubMed ID: 8777104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuromuscular blocking and cardiovascular effects of doxacurium chloride in patients receiving nitrous oxide narcotic anesthesia.
    Murray DJ; Mehta MP; Choi WW; Forbes RB; Sokoll MD; Gergis SD; Rudd GD; Abou-Donia MM
    Anesthesiology; 1988 Oct; 69(4):472-7. PubMed ID: 3177909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ; Mirakhur RK; Kumar N
    Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of edrophonium and neostigmine on the pharmacokinetics and neuromuscular effects of mivacurium.
    Szenohradszky J; Fogarty D; Kirkegaard-Nielsen H; Brown R; Sharma ML; Fisher DM
    Anesthesiology; 2000 Mar; 92(3):708-14. PubMed ID: 10719950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics.
    Mills KG; Wright PM; Pollard BJ; Scott JM; Hing JP; Danjoux G; Hunter JM
    Br J Anaesth; 1999 Nov; 83(5):727-33. PubMed ID: 10690134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.